A detailed history of Round Rock Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Round Rock Advisors, LLC holds 411 shares of LLY stock, worth $321,882. This represents 0.09% of its overall portfolio holdings.

Number of Shares
411
Previous 422 2.61%
Holding current value
$321,882
Previous $382,000 4.71%
% of portfolio
0.09%
Previous 0.09%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$772.14 - $960.02 $8,493 - $10,560
-11 Reduced 2.61%
411 $364,000
Q2 2024

Aug 02, 2024

BUY
$724.87 - $909.04 $38,418 - $48,179
53 Added 14.36%
422 $382,000
Q1 2024

Apr 24, 2024

BUY
$592.2 - $792.28 $218,521 - $292,351
369 New
369 $287,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $744B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Round Rock Advisors, LLC Portfolio

Follow Round Rock Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Round Rock Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Round Rock Advisors, LLC with notifications on news.